1074 related articles for article (PubMed ID: 15860457)
21. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.
Pan G; Li J; Zhou Y; Zheng H; Pei D
FASEB J; 2006 Aug; 20(10):1730-2. PubMed ID: 16790525
[TBL] [Abstract][Full Text] [Related]
22. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells.
Card DA; Hebbar PB; Li L; Trotter KW; Komatsu Y; Mishina Y; Archer TK
Mol Cell Biol; 2008 Oct; 28(20):6426-38. PubMed ID: 18710938
[TBL] [Abstract][Full Text] [Related]
23. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
[TBL] [Abstract][Full Text] [Related]
24. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
25. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
26. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal.
Pereira L; Yi F; Merrill BJ
Mol Cell Biol; 2006 Oct; 26(20):7479-91. PubMed ID: 16894029
[TBL] [Abstract][Full Text] [Related]
27. Comparisons between transcriptional regulation and RNA expression in human embryonic stem cell lines.
Player A; Wang Y; Bhattacharya B; Rao M; Puri RK; Kawasaki ES
Stem Cells Dev; 2006 Jun; 15(3):315-23. PubMed ID: 16846370
[TBL] [Abstract][Full Text] [Related]
28. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells.
Okumura-Nakanishi S; Saito M; Niwa H; Ishikawa F
J Biol Chem; 2005 Feb; 280(7):5307-17. PubMed ID: 15557334
[TBL] [Abstract][Full Text] [Related]
29. Role for Med12 in regulation of Nanog and Nanog target genes.
Tutter AV; Kowalski MP; Baltus GA; Iourgenko V; Labow M; Li E; Kadam S
J Biol Chem; 2009 Feb; 284(6):3709-18. PubMed ID: 19036726
[TBL] [Abstract][Full Text] [Related]
30. OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells.
Navarro P; Festuccia N; Colby D; Gagliardi A; Mullin NP; Zhang W; Karwacki-Neisius V; Osorno R; Kelly D; Robertson M; Chambers I
EMBO J; 2012 Dec; 31(24):4547-62. PubMed ID: 23178592
[TBL] [Abstract][Full Text] [Related]
31. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
32. The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs.
Lim LS; Hong FH; Kunarso G; Stanton LW
Stem Cells; 2010 Nov; 28(11):1961-9. PubMed ID: 20872845
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.
Yang J; Chai L; Fowles TC; Alipio Z; Xu D; Fink LM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19756-61. PubMed ID: 19060217
[TBL] [Abstract][Full Text] [Related]
34. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.
Sharov AA; Masui S; Sharova LV; Piao Y; Aiba K; Matoba R; Xin L; Niwa H; Ko MS
BMC Genomics; 2008 Jun; 9():269. PubMed ID: 18522731
[TBL] [Abstract][Full Text] [Related]
35. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
36. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
37. Evolution of the mammalian embryonic pluripotency gene regulatory network.
Fernandez-Tresguerres B; Cañon S; Rayon T; Pernaute B; Crespo M; Torroja C; Manzanares M
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19955-60. PubMed ID: 21048080
[TBL] [Abstract][Full Text] [Related]
38. Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19 embryonal carcinoma cells via directly activating Oct4.
Li H; Fan R; Sun M; Jiang T; Gong Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):527-32. PubMed ID: 24113379
[TBL] [Abstract][Full Text] [Related]
39. Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis.
Rizzino A; Wuebben EL
Biochim Biophys Acta; 2016 Jun; 1859(6):780-91. PubMed ID: 26992828
[TBL] [Abstract][Full Text] [Related]
40. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.
Baltus GA; Kowalski MP; Tutter AV; Kadam S
J Biol Chem; 2009 Mar; 284(11):6998-7006. PubMed ID: 19139101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
